National Institute of Diabetes and Digestive and Kidney Diseases to Grant Exclusive Patent License to Saint Louis University for Neuropathic Pain Treatment

Summary

The National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health and Department of Health and Human Services, is considering granting an exclusive, sublicensable patent license to Saint Louis University, a non-profit university in Missouri, for its rights to certain inventions and patents related to the treatment and prevention of neuropathic pain using P2Y14 antagonists.